FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Stereotaxis, Inc. [ STXS ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 06/21/2007 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 06/21/2007 | S | 122 | D | $12.04 | 0 | I | Sanderling II Limited Partnership | ||
Common Stock | 08/14/2007 | J(1) | 301,745 | D | (2) | 0 | I | Sanderling Management Limited, FBO Sanderling Ventures Limited | ||
Common Stock | 781,351 | I | Sanderling Venture Partners II, L.P. | |||||||
Common Stock | 15,000 | I | Sanderling Mgmt. LLC 401K Pension Profit Sharing Plan | |||||||
Common Stock | 532,758 | I | Sanderling IV Biomedical Co-Investment Fund, L.P. | |||||||
Common Stock | 224,515 | I | Sanderling Venture Partners IV Co-Investment Fund, L.P. | |||||||
Common Stock | 110,971 | I | Sanderling V Beteiligungs GmbH & Co. KG | |||||||
Common Stock | 397,164 | I | Sanderling V Biomedical Co-Investment Fund, L.P. | |||||||
Common Stock | 119,566 | I | Sanderling V Limited Partnership | |||||||
Common Stock | 677,906 | I | Sanderling Venture Partners V Co-Investment Fund, L.P. | |||||||
Common Stock | 1,242 | I | Sanderling Ventures Management V | |||||||
Common Stock | 145,506 | I | Sanderling Venture Partners VI Co-Investment Fund | |||||||
Common Stock | 2,816 | I | Sanderling VI Beteiligungs GmbH & Co KG | |||||||
Common Stock | 3,355 | I | Sanderling VI Limited Partnership | |||||||
Common Stock | 1,532 | I | Sanderling Ventures Management VI | |||||||
Common Stock | 149,586 | D |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
1. Sanderling Management Limited, FBO Sanderling Ventures Limited distributed 301,745 shares of the issuer's common stock in a pro rata distribution to its partners on August 14, 2007. |
2. Price is not applicable to acquisitions and distributions of portfolio securities. |
/s/ Fred A. Middleton | 08/16/2007 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |